Rheological alteration of erythrocytes exposed to carbon nanotubes

Application of non-metal nanoparticles, as a novel approach, for improving the stability of blood products: 2011-2021

Despite the importance of the proper quality of blood products for safe transfusion, conventional methods for preparation and their preservation, they lack significant stability. Non-metal nanoparticles with particular features may overcome these challenges. This review study for the first time provided a comprehensive vision of the interaction of non-metal nanoparticles with each blood product (red blood cells, platelets and plasma proteins). The findings of this review on the most effective nanoparticle for improving the stability of RBCs indicate that graphene quantum dots and nanodiamonds show compatibility with RBCs. For increasing the stability of platelet products, silica nanoparticles exhibited a suppressive impact on platelet aggregation. Pristine graphene also shows compatibility with platelets. For better stability of plasma products, graphene oxide was indicated to preserve free human serum albumin from thermal shocks at low ionic strength. For increased stability of Factor VIII, mesoporous silica nanoparticles with large pores exhibit the superb quality of recovered proteins. Furthermore, 3.2 nm quantum dots exhibited anticoagulant effects. As the best promising nanoparticles for immunoglobulin stability, graphene quantum dots showed compatibility with γ-globulins. Overall, this review recommends further research on the mentioned nanoparticles as the most potential candidates for enhancing the stability and storage of blood components.

Zwitterionic peptide-functionalized highly dispersed carbon nanotubes for efficient wastewater treatment

Multi-walled carbon nanotubes (MWCNTs) have displayed great potential as catalyst carriers due to their nanoscale structure and large specific surface area. However, their hydrophobicity and poor dispersibility in water restrict their applications in aqueous environments. Herein, the dispersibility of MWCNTs was significantly enhanced with a chimeric protein MPKE which consisted of a zwitterionic peptide unit and a mussel adhesive protein unit. The MPKE could be easily attached to MWCNTs (MPKE-MWCNTs) by a simple stirring process due to the versatile adhesion ability of mussel adhesive unit. As expected, the MPKE-MWCNTs displayed outstanding dispersibility in water (>7 months), as well as in alkaline solutions (pH = 12) and organic solvents (DMSO and ethanol) due to the hydrophilicity of the zwitterionic peptide unit. Moreover, the MPKE-MWCNTs were used as silver nanoparticle carriers for the reduction of 4-nitrophenol in wastewater, with the normalized rate constant k_nor up to 32.9 s^-1 mmol^-1. Meanwhile, they also exhibited excellent biocompatibility and antibacterial activity, which were favorable for wastewater treatment. This work provides a facile strategy for MWCNT modification, functionalization and applications in aqueous environments.

Current advances in nanomaterials affecting morphology, structure, and function of erythrocytes

In recent decades, nanomaterials have been widely used in the field of biomedicine due to their unique physical and chemical properties, and have shown good prospects for in vitro diagnosis, drug delivery, and imaging. With regard to transporting nanoparticles (NPs) to target tissues or organs in the body intravenously or otherwise, blood is the first tissue that NPs come into contact with and is also considered an important gateway for targeted transport. Erythrocytes are the most numerous cells in the blood, but previous studies based on interactions between erythrocytes and NPs mostly focused on the use of erythrocytes as drug carriers for nanomedicine which were chemically bound or physically adsorbed by NPs, so little is known about the effects of nanoparticles on the morphology, structure, function, and circulation time of erythrocytes in the body. Herein, this review focuses on the mechanisms by which nanoparticles affect the structure and function of erythrocyte membranes, involving the hemocompatibility of NPs, the way that NPs interact with erythrocyte membranes, effects of NPs on erythrocyte surface membrane proteins and their structural morphology and the effect of NPs on erythrocyte lifespan and function. The detailed analysis in this review is expected to shed light on the more advanced biocompatibility of nanomaterials and pave the way for the development of new nanodrugs.

Hemocompatibility of Carbon Nanostructures

Carbon nanostructures (CNs), such as carbon nanotubes, fullerenes, carbon dots, nanodiamonds as well as graphene and its derivatives present a tremendous potential for various biomedical applications, ranging from sensing to drug delivery and gene therapy, biomedical imaging and tissue engineering. Since most of these applications encompass blood contact or intravenous injection, hemocompatibility is a critical aspect that must be carefully considered to take advantage of CN exceptional characteristics while allowing their safe use. This review discusses the hemocompatibility of different classes of CNs with the purpose of providing biomaterial scientists with a comprehensive vision of the interactions between CNs and blood components. The various complex mechanisms involved in blood compatibility, including coagulation, hemolysis, as well as the activation of complement, platelets, and leukocytes will be considered. Special attention will be paid to the role of CN size, structure, and surface properties in the formation of the protein corona and in the processes that drive blood response. The aim of this review is to emphasize the importance of hemocompatibility for CNs intended for biomedical applications and to provide some valuable insights for the development of new generation particles with improved performance and safety in the physiological environment.

Effects of polymer-coated boron nitrides with increased hemorheological compatibility on human erythrocytes and blood coagulation

BACKGROUND

Boron nitride (BN) nanomaterials are promising in biomedical research owing to their large surface area, graphene-like structure, and chemical and thermal properties. However, the toxicological effects of BN on erythrocytes and blood coagulation remain uninvestigated.

OBJECTIVE

The aims of our study were to synthesize glycol chitosan (GC)- and hyaluronic acid (HA)-coated BNs, and to investigate the effects of these BNs on human cancer cells, erythrocytes, and whole blood.

METHODS

We prepared hemocompatible forms of BN coated with GC and HA, and evaluated them using cell uptake/viability tests, hemolysis analysis and FE-SEM, as well as through hemorheological evaluation methods such as RBC deformability and aggregation, and blood coagulation.

RESULTS

GC/BN and HA/BN were both ∼200 nm, were successfully taken into cells, and emitted blue fluorescence. Both BNs were less toxic than bare BN, even at higher concentrations. The aggregation index of human red blood cells (RBCs) after 2 h incubation with BN, GC/BN, and HA/BN was greatly influenced, whereas RBC deformability did not dramatically change.

CONCLUSIONS

We found that GC/BN affected the intrinsic coagulation pathway, whereas both GC/BN and HA/BN affected the extrinsic pathway. Therefore, HA/BN is less detrimental to RBCs and blood coagulation dynamics than bare BN and GC/BN.

Hemocompatibility of inhaled environmental nanoparticles: Potential use of in vitro testing

Hemocompatibility testing is an important part in the evaluation of nano-based medicines. However, it is not systematically used for the assessment of environmental particles since they do not come in contact with blood immediately. Studies on human exposure to air-borne particles and pulmonary exposure of rodents have reported alterations in blood physiology. It is not clear, whether these effects are majorly caused by tissue inflammation or translocated particles in blood. This review addresses the question, if in vitro hemocompatibility testing could help in the risk evaluation of inhaled particles. Particle blood concentrations were estimated based on exposure levels, ventilation volume, deposition rate, lung surface area, and permeability of the alveolar epithelium to particles. The categories of hemocompatibility, thrombosis, coagulation, platelets, hematology, and immunology, were introduced. Also, concentrations of ultrafine particles, silver nanoparticles, carbon nanotubes that caused adverse effects in human blood samples were compared to the estimated concentrations of translocated particles. The comparison suggested that, it is unlikely for translocated nanoparticles to be the sole cause of adverse blood effects. Nevertheless, the testing of specific hemocompatibility parameters (hemolysis and clotting) in healthy blood might help to compare biological effect of inhaled particles containing different amounts of contamination. Testing of samples from healthy and diseased persons might help to identify pathological dispositions that increase the possibility of adverse reaction of nanoparticles in blood.

Hemorheological characteristics of red blood cells exposed to surface functionalized graphene quantum dots

Graphene quantum dots (GQDs) are potential candidates for various biomedical applications such as drug delivery, bioimaging, cell labeling, and biosensors. However, toxicological information on their effects on red blood cells (RBCs) and the mechanisms involved remain unexplored. To the best of our knowledge, our study is the first to investigate the toxicity effects of three GQDs with different surface functionalizations on the hemorheological characteristics of human RBCs, including hemolysis, deformability, aggregation, and morphological changes. RBCs were exposed to three different forms of GQDs (non-functionalized, hydroxylated, and carboxylated GQDs) at various concentrations (0, 500, 750, and 1000 μg/mL) and incubation times (0, 1, 2, 3, or 4 h). The rheological characteristics of the RBCs were measured using microfluidic-laser diffractometry and aggregometry. Overall, the hemolysis rate and rheological alterations of the RBCs were insignificant at a concentration less than 500 μg/mL. Carboxylated GQDs were observed to have more substantial hemolytic activity and caused abrupt changes in the deformability and aggregation of the RBCs than the non-functionalized or hydroxylated GQDs at concentrations >750 μg/mL. Our findings indicate that hemorheological assessments could be utilized to estimate the degree of toxicity to cells and to obtain useful information on safety sheets for nanomaterials.